Internal medicine

Treatment doctor tested on himself can put others into remission

Five years ago, David C. Fajgenbaum both a Penn Medicine researcher and patient, tried an experimental treatment for Castleman disease based on his laboratory research findings in the hopes of saving his own life. He has been in remission ever since.

Penn Today Staff

A cohort study comes of age

For nearly two decades, a major national study of kidney disease led and coordinated at Penn has defined key risk factors in an all-too-common silent epidemic.

Steve Graff

How to quell a cytokine storm

An international team finds new ways to dampen an overactive immune system, and can influence new drug targets for lupus and other autoimmune disorders.

Penn Today Staff

We’re only as good as our microbiomes are happy

Understanding the microbiome, the collection of bacteria, viruses, and fungi in the gut, is helping to sort out the intricacies of diet, chronobiology, cancer treatment, and more.

Penn Today Staff



In the News


Philadelphia Inquirer

E-Cigarettes Disappoint in a Workplace Quit-Smoking Study

The Perelman School of Medicine’s Scott Halpern led a study on the effects of vaping on smoking cessation. Halpern found that e-cigarettes were no more helpful than other stop-smoking tools, and that “the very best way to help them quit is to offer them money.”

FULL STORY →



WHYY (Philadelphia)

New Blood Test for Pregnant Women Could Predict Preterm Birth

The Perelman School of Medicine’s Michal Elovitz discussed the results from her research exploring methods for predicting preterm births. The study’s results were published in Science.

FULL STORY →